Results 51 to 60 of about 5,200 (157)

Transcatheter mitral valve repair for primary mitral regurgitation

open access: yesReviews in Cardiovascular Medicine, 2022
The landscape of transcatheter mitral valve repair devices continues to expand, with many technologies undergoing investigation in patients with primary mitral regurgitation (MR).
Rowa H. Attar   +2 more
doaj   +1 more source

MELD score predicts outcomes in patients with advanced heart failure: A longitudinal evaluation

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 839-847, April 2025.
Abstract Aims Advanced heart failure (AHF) is characterized by recurrent episodes of haemodynamic instability and frequent hospitalizations, leading to a progressive decline in quality of life and high mortality rates. The objectives of this study were to evaluate the effect of the model for end‐stage liver disease (MELD) score and its variations in ...
Francesco Curcio   +10 more
wiley   +1 more source

Mitraclip Plus Medical Therapy Versus Medical Therapy Alone for Functional Mitral Regurgitation: A Meta-Analysis

open access: yesCardiology and Therapy, 2019
Introduction The purpose of this meta-analysis is to compare the efficacy of MitraClip plus medical therapy versus medical therapy alone in patients with functional mitral regurgitation (FMR). FMR caused by left ventricular dysfunction is associated with
Sunny Goel   +10 more
doaj   +1 more source

Heart team approach in treatment of mitral regurgitation: patient selection and outcome

open access: yesOpen Heart, 2020
Objective A multidisciplinary heart valve team is recommended for the evaluation of treatment in patients with valvular heart disease, but evidence supporting this concept is lacking.
Mischa Külling   +15 more
doaj   +1 more source

Interventional therapies for chronic heart failure: An overview of recent developments

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo   +7 more
wiley   +1 more source

Prognostic role of TAPSE to PASP ratio in outpatients with left ventricular systolic dysfunction

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 912-922, April 2025.
Abstract Aims Few data are available regarding the role of tricuspid annulus plane systolic excursion to pulmonary artery systolic pressure (TAPSE/PASP), a measurement of right ventricular to pulmonary artery coupling, in patients with chronic heart failure and left ventricular systolic dysfunction.
Mauro Riccardi   +9 more
wiley   +1 more source

Cirugía tras implante fallido del dispositivo MitraClip®

open access: yesCirugía Cardiovascular, 2020
Resumen: En el presente trabajo exponemos el caso de un hombre de 70 años, pluripatológico, con riesgo quirúrgico alto (STS score del 13,8%) e insuficiencia mitral masiva tras implante fallido del dispositivo MitraClip® que precisó reemplazo valvular ...
Gertrudis Parody Cuerda   +5 more
doaj   +1 more source

MitraClip to the rescue in cardiogenic shock: Case series from a single center

open access: yesHeart Views, 2023
Cardiogenic shock (CS) in the setting of acute coronary syndrome carries detrimental consequences and high levels of mortality and morbidity if not managed promptly.
Ashraf Omer Elamin Ahmed   +5 more
doaj   +1 more source

Combined MitraClip implantation and left atrial appendage occlusion using the Watchman device: A case series from a referral center

open access: yesRevista Portuguesa de Cardiologia, 2017
Introduction: Patients referred for percutaneous transcatheter mitral valve repair using the MitraClip® system frequently have atrial fibrillation, which imposes additional challenges due to the need for oral anticoagulation.
Ana Rita G. Francisco   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy